156 related articles for article (PubMed ID: 8844436)
1. Low-density lipoprotein-apheresis in two patients with extremely elevated lipoprotein (a) levels.
Bambauer R; Schiel R; Klinkmann J; Latza R
J Clin Apher; 1996; 11(2):78-80. PubMed ID: 8844436
[TBL] [Abstract][Full Text] [Related]
2. LDL-apheresis in two patients with extremely elevated lipoprotein (a) levels.
Bambauer R; Schiel R; Keller HE; Latza R
Int J Artif Organs; 1995 May; 18(5):286-90. PubMed ID: 8567105
[TBL] [Abstract][Full Text] [Related]
3. LDL-apheresis in treatment of two patients with heterozygous familial hypercholesterolemia and extremely elevated lipoprotein (a) levels.
Bambauer R; Schiel R; Latzo R; Klinkmann J
Transfus Sci; 1995 Dec; 16(4):375-81. PubMed ID: 10159508
[TBL] [Abstract][Full Text] [Related]
4. LDL-apheresis as long-term treatment in severe hyperlipidemia using differing methods.
Bambauer R; Schiel R; Latza R; Schneidewind JM
ASAIO J; 1999; 45(5):408-12. PubMed ID: 10503616
[TBL] [Abstract][Full Text] [Related]
5. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
Bambauer R; Schneidewind JM; Latza R
ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
[TBL] [Abstract][Full Text] [Related]
6. LDL apheresis in clinical practice: long-term treatment of severe hyperlipidemia.
Bambauer R; Schiel R; Latza R; Klinkmann J; Schneidewind JM
Ther Apher; 1997 Feb; 1(1):49-54. PubMed ID: 10225781
[TBL] [Abstract][Full Text] [Related]
7. Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies.
Bambauer R; Schiel R; Latza R
Ther Apher; 2000 Jun; 4(3):213-7. PubMed ID: 10910023
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
Gordon BR; Saal SD
J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein (a) levels.
Bambauer R; Schiel R; Keller HE; Klinkmann J; Latza R
Artif Organs; 1996 Apr; 20(4):340-3. PubMed ID: 9139621
[TBL] [Abstract][Full Text] [Related]
10. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
11. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial.
Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K
Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134
[TBL] [Abstract][Full Text] [Related]
13. LDL apheresis: a novel technique (LIPOCOLLECT 200).
Stefanutti C; Di Giacomo S; Mazzarella B; Castelli A
Artif Organs; 2009 Dec; 33(12):1103-8. PubMed ID: 19995360
[TBL] [Abstract][Full Text] [Related]
14. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells.
Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P
ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein apheresis: clinical results with different methods.
Bambauer R
Artif Organs; 2002 Feb; 26(2):133-9. PubMed ID: 11879241
[TBL] [Abstract][Full Text] [Related]
16. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
17. One year experience with a low density lipoprotein apheresis system.
Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
[TBL] [Abstract][Full Text] [Related]
19. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre.
Archontakis S; Pottle A; Hakim N; Ilsley C; Barbir M
Int J Clin Pract; 2007 Nov; 61(11):1834-42. PubMed ID: 17935547
[TBL] [Abstract][Full Text] [Related]
20. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
